My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Epilim Intravenous 400mg powder and solvent for solution for injection or infusion



Sanofi-Aventis Ireland Limited T/A SANOFIPA0540/150/013

Main Information

Trade NameEpilim Intravenous 400mg powder and solvent for solution for injection or infusion
Active SubstancesSodium valproate
Dosage FormPowder and solvent for solution for injection/infusion
Licence HolderSanofi-Aventis Ireland Limited T/A SANOFI
Licence NumberPA0540/150/013

Group Information

ATC CodeN03AG Fatty acid derivatives
N03AG01 valproic acid

Status

License statusAuthorised
Licence Issued15/12/1998
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print